ScanBalt Business Partner Seach: Ivex Lab – Development of preclinical models aiding novel cancer drug efficacy studies in vivo
We look for partners and investors who are interested in cancer drug development. Our goal is to produce preclinical models with better predictive value than currently available. We focus to whole-body bioluminescence and fluorescence imaging in vivo, that enables continuous monitoring of disease progression/regression. We clone and produce lentiviral vectors expressing palettes of novel fluorescent proteins. Attached image shows pseudocoloured image of the mouse with five tumors each expressing a different fluorescent protein.
10 January 2023
Workshop #3: Reducing Pharmaceutical Residuals in the Baltic Sea Region – Comparative Analysis and Assessment of Possibilities | 9 February at 11:00-15:05 EET
4 January 2023
EDAH - a new European project ahead